4.7 Article

Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy

Journal

PHYTOTHERAPY RESEARCH
Volume 37, Issue 5, Pages 1911-1923

Publisher

WILEY
DOI: 10.1002/ptr.7709

Keywords

alkamides; chicoric acid; Echinacea purpurea; oxaliplatin; polyphenols

Ask authors/readers for more resources

Chemotherapy-induced neuropathy is a major side effect of anticancer drugs, causing chronic pain and reduced quality of life. Echinacea extracts (EP4-R-E and EP4-R-BU) showed potential in treating oxaliplatin-induced neuropathic pain. EP4-R-E exerted anti-hyperalgesic effects through the endocannabinoid system with alkamides, while EP4-R-BU exhibited anti-neuropathic properties mainly through chicoric acid. The extracts have therapeutic potential through the activity of alkamides and the protective properties of polyphenols.
Chemotherapy-induced neuropathy represents the main dose-limiting toxicity of several anticancer drugs, such as oxaliplatin, leading to chronic pain and an impairment of the quality of life. Echinacea purpurea n-hexane extract (EP4-R-E; rich in alkamides) and butanolic extract (EP4-R-BU; rich in polyphenols) have been characterized and tested in an in vivo model of oxaliplatin-induced neuropathic pain, addressing the endocannabinoid system with alkamides and counteracting the redox imbalance with polyphenols. Thermal hypersensitivity was evaluated by the Cold Plate test. EP4-R-E showed a dose-dependent anti-hyperalgesic profile. The extract was more effective than its main constituent, dodeca-2 E,4 E,8Z,10 E/Z-tetraenoic acid isobutylamide (18 mg kg(-1), twofold to equimolar EP4-R-E 30 mg kg(-1)), suggesting a synergy with other extract constituents. Administration of cannabinoid type 2 (CB2) receptor-selective antagonist completely blocked the anti-allodynic effect of EP4-R-E, differently from the antagonism of CB1 receptors. EP4-R-BU (30 mg kg(-1)) exhibited anti-neuropathic properties too. The effect was mainly exerted by chicoric acid, which administered alone (123 mu g kg(-1), equimolar to EP4-R-BU 30 mg kg(-1)) completely reverted oxaliplatin-induced allodynia. A synergy between different polyphenols in the extract had not been highlighted. Echinacea extracts have therapeutic potential in the treatment of neuropathic pain, through both alkamides CB2-selective activity and polyphenols protective properties.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available